Unresponsive correlated motion in alpha7 nAChR to halothane binding explains its functional insensitivity to volatile anesthetics.
Neuronal nicotinic acetylcholine receptors (nAChRs) have been implicated as targets for general anesthetics, but the functional responses to anesthetic modulation vary considerably among different subtypes of nAChRs. Inhaled general anesthetics, such as halothane, could effectively inhibit the channel activity of the alpha4beta2 nAChR but not the homologous alpha7 nAChR. To understand why alpha7 is insensitive to inhaled general anesthetics, we performed multiple sets of 20 ns molecular dynamics (MD) simulations on the closed- and open-channel alpha7 in the absence and presence of halothane and critically compared the results with those from our studies on the alpha4beta2 nAChR (Liu et al. J. Phys. Chem. B 2009, 113, 12581 and Liu et al. J. Phys. Chem. B 2010, 114, 626). Several halothane binding sites with fairly high binding affinities were identified in both closed- and open-channel alpha7, suggesting that a lack of sensitive functional responses of the alpha7 nAChR to halothane in the previous experiments was unlikely due to a lack of halothane interaction with alpha7. The binding affinities of halothane in alpha7 seemed to be protein conformation-dependent. Overall, halothane affinity was higher in the closed-channel alpha7. Halothane binding to alpha7 did not induce profound changes in alpha7 structure and dynamics that could be related to the channel function. In contrast, correlated motion of the open-channel alpha4beta2 was reduced substantially in the presence of halothane, primarily due to the more susceptible nature of beta2 to anesthetic modulation. The amphiphilic extracellular and transmembrane domain interface of the beta2 subunit is attractive to halothane and is susceptible to halothane perturbation, which may be why alpha4beta2 is functionally more sensitive to halothane than alpha7.
Mowrey
David
D
Department of Anesthesiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA.
Haddadian
Esmael J
EJ
Liu
Lu Tian
LT
Willenbring
Dan
D
Xu
Yan
Y
Tang
Pei
P
D018685:Anesthetics, Inhalation / Q000737:chemistry / Q000378:metabolism; D000818:Animals; D001665:Binding Sites; D006221:Halothane / Q000737:chemistry / Q000378:metabolism; D008958:Models, Molecular; D056004:Molecular Dynamics Simulation; D009474:Neurons / Q000378:metabolism; D011485:Protein Binding; D011487:Protein Conformation; D011978:Receptors, Nicotinic / Q000737:chemistry / Q000378:metabolism; D014101:Torpedo; D064569:alpha7 Nicotinic Acetylcholine Receptor
D018685:Anesthetics, Inhalation; D011978:Receptors, Nicotinic; D064569:alpha7 Nicotinic Acetylcholine Receptor; C403531:nicotinic receptor alpha4beta2; D006221:Halothane
Neuron. 2004 Mar 25;41(6):907-14
15046723
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W610-4
15215461
Anesthesiology. 1997 Apr;86(4):859-65
9105230
J Gen Physiol. 2004 Apr;123(4):341-56
15051806
Biophys J. 2003 Nov;85(5):3007-18
14581202
J Mol Graph. 1996 Dec;14(6):354-60, 376
9195488
Biochemistry. 2003 Nov 25;42(46):13457-67
14621991
EMBO J. 2005 Apr 20;24(8):1512-22
15791209
EMBO J. 2009 Oct 7;28(19):3040-51
19696737
Biophys J. 2007 Sep 15;93(6):1895-905
17513367
Fold Des. 1997;2(3):173-81
9218955
Pharmacol Ther. 2006 Sep;111(3):729-70
16483665
J Biol Chem. 2005 Mar 4;280(9):8443-51
15591050
J Neurosci. 2009 Mar 11;29(10):3189-99
19279256
Biophys J. 2008 Mar 1;94(5):1681-8
17993502
J Phys Chem B. 2007 Dec 27;111(51):14186-92
18052271
J Physiol. 2002 Apr 15;540(Pt 2):425-34
11956333
J Biol Chem. 2003 Sep 5;278(36):34079-83
12826676
J Comput Chem. 2005 Dec;26(16):1781-802
16222654
J Biol Chem. 2009 Sep 4;284(36):24176-84
19605349
J Phys Chem B. 1998 Apr 30;102(18):3586-616
24889800
Nucleic Acids Res. 2003 Jul 1;31(13):3784-8
12824418
J Gen Physiol. 2007 Dec;130(6):547-58
18040057
Biochim Biophys Acta. 2010 Feb;1798(2):161-6
19715664
Biophys J. 2007 Oct 15;93(8):2622-34
17573436
J Mol Biol. 2005 Mar 4;346(4):967-89
15701510
Phys Rev Lett. 1996 Aug 26;77(9):1905-1908
10063201
J Neurosci. 2001 Oct 15;21(20):7993-8003
11588172
Mol Pharmacol. 2001 Apr;59(4):732-43
11259617
Biophys J. 2008 Jun;94(11):4464-72
18310239
N Engl J Med. 2003 May 22;348(21):2110-24
12761368
Proc Biol Sci. 1992 Oct 22;250(1327):11-7
1281328
J Biol Chem. 2002 Mar 22;277(12):10367-73
11741933
J Clin Invest. 2003 Feb;111(4):497-505
12588888
FASEB J. 2005 Apr;19(6):567-76
15791007
J Physiol. 2000 Sep 15;527 Pt 3:515-28
10990538
Nature. 2009 Jan 1;457(7225):115-8
18987630
J Gen Physiol. 2002 Oct;120(4):483-96
12356851
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16035-40
12438684
Biochim Biophys Acta. 1997 Jan 14;1323(1):154-62
9030222
Int Rev Neurobiol. 2001;48:141-66
11526737
J Phys Chem B. 2008 Nov 6;112(44):13981-90
18847252
J Mol Biol. 1993 Jun 20;231(4):1049-67
8515464
Bioinformatics. 2005 Jul 1;21(13):2978-87
15860562
Anesthesiology. 1997 Apr;86(4):760-2
9105218
Nature. 2009 Jan 1;457(7225):111-4
18987633
J Biol Chem. 2003 Dec 12;278(50):50151-7
14525990
J Phys Chem B. 2008 Nov 13;112(45):14312-8
18821786
Proteins. 2007 Sep 1;68(4):948-60
17546671
Proc Natl Acad Sci U S A. 2005 May 10;102(19):6813-8
15857954
Nature. 2004 Aug 19;430(7002):896-900
15318223
Biophys J. 1997 Apr;72(4):1676-82
9083671
J Phys Chem B. 2009 Sep 17;113(37):12581-9
19697903
Biophys J. 1999 Aug;77(2):739-46
10423422
J Mol Biol. 2006 Jan 13;355(2):310-24
16307758
J Neurosci. 2009 Jan 28;29(4):918-29
19176801
J Phys Chem B. 2010 Jan 14;114(1):626-32
20014754
Biophys J. 2005 Oct;89(4):2350-6
16040747